A detailed history of Anchor Investment Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Anchor Investment Management, LLC holds 52,728 shares of ABT stock, worth $6.07 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
52,728
Previous 52,496 0.44%
Holding current value
$6.07 Million
Previous $5.97 Billion 8.17%
% of portfolio
0.56%
Previous 0.63%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 20, 2024

BUY
$100.73 - $112.44 $23,369 - $26,086
232 Added 0.44%
52,728 $5.48 Billion
Q1 2024

May 15, 2024

BUY
$109.52 - $120.96 $210,716 - $232,727
1,924 Added 3.8%
52,496 $5.97 Billion
Q4 2023

Jan 02, 2024

BUY
$90.19 - $110.4 $4.56 Million - $5.58 Million
50,572 New
50,572 $5.57 Billion
Q3 2023

Jan 02, 2024

SELL
$95.53 - $114.62 $138,900 - $166,657
-1,454 Reduced 2.8%
50,419 $4.88 Billion
Q2 2023

Jan 02, 2024

SELL
$100.78 - $112.29 $132,223 - $147,324
-1,312 Reduced 2.47%
51,873 $5.66 Billion
Q1 2023

Jan 02, 2024

BUY
$96.86 - $114.01 $104,027 - $122,446
1,074 Added 2.06%
53,185 $5.39 Billion
Q4 2022

Jan 02, 2024

BUY
$95.06 - $111.52 $146,297 - $171,629
1,539 Added 3.04%
52,111 $5.72 Billion
Q3 2022

Jan 02, 2024

BUY
$96.76 - $112.03 $292,021 - $338,106
3,018 Added 5.97%
53,590 $5.19 Billion
Q2 2022

Jan 02, 2024

SELL
$102.07 - $123.37 $146,164 - $176,665
-1,432 Reduced 2.62%
53,214 $5.78 Billion
Q1 2022

Jan 02, 2024

BUY
$114.02 - $139.04 $153,584 - $187,286
1,347 Added 2.53%
54,646 $6.47 Billion
Q4 2021

Jan 02, 2024

SELL
$115.53 - $141.46 $283,164 - $346,718
-2,451 Reduced 4.4%
53,299 $7.5 Billion
Q3 2021

Jan 02, 2024

BUY
$116.66 - $129.06 $604,065 - $668,272
5,178 Added 10.24%
55,750 $6.59 Billion
Q2 2021

Jan 02, 2024

SELL
$105.79 - $124.53 $156,992 - $184,802
-1,484 Reduced 2.61%
55,291 $6.41 Billion
Q1 2021

Jan 02, 2024

BUY
$108.84 - $128.23 $354,274 - $417,388
3,255 Added 6.08%
56,775 $6.8 Billion
Q4 2020

Jan 02, 2024

SELL
$105.0 - $114.42 $124,950 - $136,159
-1,190 Reduced 2.18%
53,520 $5.86 Billion
Q3 2020

Jan 02, 2024

BUY
$91.64 - $111.29 $379,206 - $460,518
4,138 Added 8.18%
54,710 $5.95 Billion
Q2 2020

Jan 02, 2024

SELL
$76.57 - $98.0 $21,592 - $27,636
-282 Reduced 0.52%
54,133 $4.95 Billion
Q1 2020

Jan 02, 2024

SELL
$62.82 - $91.86 $40,204 - $58,790
-640 Reduced 1.16%
54,415 $4.29 Billion
Q4 2019

Jan 02, 2024

BUY
$78.51 - $87.4 $202,634 - $225,579
2,581 Added 4.92%
55,055 $4.78 Billion
Q3 2019

Jan 02, 2024

BUY
$81.84 - $88.74 $155,659 - $168,783
1,902 Added 3.76%
52,474 $4.39 Billion
Q2 2019

Jan 02, 2024

BUY
$72.88 - $85.0 $12,025 - $14,025
165 Added 0.31%
52,667 $4.43 Billion
Q1 2019

Jan 02, 2024

SELL
$66.22 - $80.06 $8,873 - $10,728
-134 Reduced 0.25%
52,502 $4.2 Billion
Q4 2018

Jan 02, 2024

BUY
$65.56 - $74.27 $36,975 - $41,888
564 Added 1.08%
52,636 $3.81 Billion
Q3 2018

Jan 02, 2024

BUY
$60.81 - $73.36 $91,215 - $110,040
1,500 Added 2.97%
52,072 $3.82 Billion
Q2 2018

Jan 03, 2024

BUY
$57.57 - $63.54 $133,274 - $147,095
2,315 Added 4.58%
52,887 $3.23 Billion
Q1 2018

Jan 03, 2024

SELL
$56.27 - $63.62 $42,202 - $47,715
-750 Reduced 1.4%
52,736 $3.16 Billion
Q4 2017

Jan 03, 2024

SELL
$53.68 - $57.47 $86,961 - $93,101
-1,620 Reduced 2.94%
53,486 $3.05 Billion
Q3 2017

Jan 03, 2024

SELL
$48.06 - $53.64 $24,798 - $27,678
-516 Reduced 0.93%
55,106 $2.94 Billion
Q2 2017

Jan 03, 2024

BUY
N/A
5,050 Added 9.99%
55,622 $2.7 Billion
Q1 2017

Jan 03, 2024

BUY
N/A
5,034 Added 10.12%
54,792 $2.43 Billion
Q4 2016

Jan 03, 2024

BUY
N/A
1,770 Added 3.69%
49,758 $1.91 Billion
Q3 2016

Jan 03, 2024

SELL
N/A
-175 Reduced 0.36%
47,988 $2.03 Billion
Q2 2016

Jan 03, 2024

SELL
N/A
-2,409 Reduced 4.76%
48,163 $1.89 Billion
Q1 2016

Jan 03, 2024

BUY
N/A
421
50,993 $2.13 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.